Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 2/20 | 0.50 |
| ▸ | BIRC2 | Q13490 | 2/20 | 0.50 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | BRD2 | P25440 | 1/20 | 0.35 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13826643 | 0.80 | XIAP (0.50) | XIAPBIRC2BRD4BRD2BRD3 | |
| SCHEMBL7416621 | 0.75 | XIAP (0.40) | XIAPBIRC2 | |
| SCHEMBL7416890 | 0.73 | XIAP (0.50) | XIAPBIRC2BRD4BRD2BRD3 | |
| SCHEMBL7414764 | 0.72 | XIAP (0.33) | XIAPBIRC2 | |
| SCHEMBL7415042 | 0.70 | BRD4 (0.51) | XIAPBIRC2BRD4BRD2MEN1 | |
| SCHEMBL13732112 | 0.69 | XIAP (0.52) | XIAPBIRC2 | |
| Hydrochloric Acid SCHEMBL13733105 | 0.68 | XIAP (0.51) | XIAPBIRC2 | |
| SCHEMBL23600150 | 0.68 | MEN1 (0.32) | MEN1KMT2A | |
| SCHEMBL30336256 | 0.68 | BRD4 (0.53) | BRD4BRD2BRD3MEN1KMT2A | |
| SCHEMBL29209001 | 0.68 | BRD4 (0.53) | BRD4BRD2BRD3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5002944-A | Compounds having cardiotonic activity | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-03-26 | — | — | US | disclosed |
| EP-0333727-A1 | HETEROCYCLIC SUBSTITUTED BICYCLOUREAS HAVING CARDIOTONIC ACTIVITY | RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) | 1989-09-27 | — | — | EP | disclosed |
| US-4859672-A | Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone | RORER PHARMACEUTICAL CORPORATION (US) | 1989-08-22 | — | — | US | disclosed |
| WO-1988003025-A1 | HETEROCYCLIC SUBSTITUTED BICYCLOUREAS HAVING CARDIOTONIC ACTIVITY | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1988-05-05 | — | — | WO | disclosed |